COMMUNIQUÉS West-GlobeNewswire

U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia
13/01/2026
Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine in first line unfit acute myeloid leukemia PARIS, FRANCE, 13 JANUARY 2026 - Ipsen (Euronext: [...]
SPINEWAY : Chiffre d’affaires annuel 2025 de 12,4 ME avec une accélération des ventes au T4 2025 (+34%)
13/01/2026
Ecully, le 13 janvier 2026 – 18h30 SPINEWAY Chiffre d’affaires annuel 2025 de 12,4 M€ avec une accélération des ventes au T4 2025 (+34%) En milliers d’euros 2025 2024 Variation en % CA 1 er semestre 5 573 6 535 - 15% CA [...]
SPINEWAY : 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%)
13/01/2026
Ecully, January 13, 2026 – 6:30 p.m. SPINEWAY 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) In thousands of euros 2025 2024 Change as a % H1 revenue 5,573 6,535 -15% H2 revenue 6,857 5, [...]
Metabo Drops Examined: Is It Legit for Weight Loss? Safety Checks and Consumer Analysis 2026
13/01/2026
New York, NY, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Consumer interest in supplement legitimacy continues to rise as transparency becomes a deciding factor in purchasing decisions. Searches that include phrases such as “Is [...]
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
13/01/2026
VALENCIA, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced unaudited [...]
Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues between $17.0 Million and $17.5 Million, Representing Approximately 35% Year-Over-Year Growth
13/01/2026
Fourth quarter results represent highest quarterly revenue in Company’s history Q4 year-over-year growth of 35% to 39% driven by sales execution of Ameluz ® Full year 2025 revenues also expected to show double-digit [...]
Pheton Holdings Ltd Announces Corporate Name Change and Stock Ticker Symbol Change
13/01/2026
BEIJING, China, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products [...]
NetraMark Announces Private Placement Financing
13/01/2026
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials [...]
Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
13/01/2026
The minimally dilutive funding will accelerate Pelthos’ highly successful commercialization efforts for its lead product, ZELSUVMI™ (berdazimer) topical gel, 10.3% for the treatment of molluscum contagiosum, two newly [...]
LifeRx Formally Launches Nationwide ED & Hair Loss Treatment Programs After Strong Early Traction
13/01/2026
Cherry Hill, NJ, Jan. 13, 2026 (GLOBE NEWSWIRE) -- LifeRx, a trusted telehealth and wellness company specializing in metabolic, hormonal, cellular, performance, and men's health, today announces the formal national [...]
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
13/01/2026
Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic system FORT LAUDERDALE, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS [...]
Polyrizon to Explore Revenue-Generating Investment Opportunities in High-Growth Sectors, Leveraging Strong Cash Position and Debt-Free Balance Sheet
13/01/2026
Company Remains Fully Committed to Advancing Its Core Intranasal Medical Pipeline, alongside examining new opportunities including in fields of aviation, AI and defense Raanana, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE [...]
Propanc Biopharma Provides Shareholder Update
13/01/2026
CEO Highlights Significant Progress Achieved & Outlines Ambitious Plans for 2026 MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a [...]
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
13/01/2026
– Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials – This next-generation anthracycline demonstrates safety and promising early activity in treating multiple oncology [...]
Nu-Tek BioSciences renforce son leadership mondial en matière d’approvisionnement grâce au renouvellement de sa certification Halal
13/01/2026
Ce renouvellement marque plus d’une décennie de conformité Halal, sécurisant les chaînes d’approvisionnement essentielles pour les marchés de croissance biopharmaceutiques jusqu’en 2026 et au-delà. MINNETONKA, Minnesota [...]
Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal
13/01/2026
Renewal marks over a decade of Halal compliance, securing critical supply chains for biopharmaceutical growth markets through 2026 and beyond. MINNETONKA, Minn., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Nu-Tek BioSciences, the [...]
Dror Secures Israeli Regulatory Approval to Market and Sell Its Next Generation Smile Correction Solution
13/01/2026
AMAR regulatory approval will allow the Company to launch ZSmile in Israel in 2026 as a precursor to a larger product launch in the US and Europe JERUSALEM, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. (" [...]
AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39
13/01/2026
KAI 12L, the AI powering Kardia 12L, adds five new detections to further expand diagnostic capabilities for the world's first handheld 12-lead ECG with a unique single-cable design. MOUNTAIN VIEW, Calif., Jan. 13, 2026 [...]
ClinNEXUS Appoints Jovan Hollins to Chief Operating Officer
13/01/2026
- A seasoned healthcare executive with nearly two decades of leadership experience, Mr. Jovan Hollins will lead ClinNEXUS’ operations at a key inflection point in its growth cycle – LOS ANGELES, Jan. 13, 2026 (GLOBE [...]

Pages